Global  

Moderna’s COVID-19 vaccine trial shows promising early results, it says

ChicagoTribune Monday, 18 May 2020
The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the virus, its manufacturer, Moderna, announced Monday.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

COVID-19 Vaccine Trial At UIC Delayed Until The End Of July [Video]

COVID-19 Vaccine Trial At UIC Delayed Until The End Of July

A researcher for the Moderna vaccine says the testing at the University of Illinois at Chicago won't start until the end of the month at the earliest.

Credit: CBS 2 Chicago     Duration: 00:28Published
Greenville clinic selected to run COVID-19 vaccine trial [Video]

Greenville clinic selected to run COVID-19 vaccine trial

Vitalink Research was selected by Moderna to run the trial.

Credit: WYFF     Duration: 01:27Published
Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results [Video]

Inovio Pharmaceuticals COVID-19 Vaccine Shows Positive Early-Stage Test Results

The company says it hopes to get data supporting the effectiveness of its COVID-19 vaccine early next year.

Credit: CBS 3 Philly     Duration: 00:53Published

Related news from verified sources

Moderna Coronavirus Vaccine Trial Shows Promising Early Results

The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the infection, the manufacturer,...
Seattle Times

Early results from Moderna vaccine trial show participants developed antibodies against coronavirus

Study subjects who received Moderna's COVID-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes...
CTV News Also reported by •USATODAY.comFT.comSBS

Wall Street slumps as Moderna shares dive on report questioning trial results

A report questioning the encouraging results of Moderna's vaccine trial sends Wall Street lower in late trade.
The Age Also reported by •NYTimes.com

Tweets about this